Abstract
Abstract: Significant strides persist in advancing our comprehension of the diverse dimensions of osteoarthritis (OA) biology. In this overview, we delineate the notable breakthroughs in this domain and the headway achieved in the pursuit of therapeutic development over the preceding year. This examination spotlights pertinent publications identified through a PubMed search, encompassing the timeframe from late November 2022 to late November 2023. Advancements in unraveling the cellular and molecular mechanisms underlying various facets of OA biology are uncovering innovative therapeutic targets for modifying the course of the disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
